Lexaria to Highlight its DehydraTECHTM Technology at

New Post Public Reply Private Reply Replies (0) Message Board
Kgem
407


Lexaria to Highlight its DehydraTECHTM Technology at Four Upcoming Investor Conferences


DECEMBER 07, 2020 6:45AM EST

-Benzinga Global Small Cap Conference on December 8th
-LD Micro Main Event on Dec 15th
-H.C. Wainwright BioConnect, held on Jan 11-14
-Virtual Biotech Showcase, held on Jan 11-14

KELOWNA, BC / ACCESSWIRE / December 7, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria" , a global innovator in drug delivery platforms, announced today that its Chairman & CEO Chris Bunka is scheduled to present at four upcoming investor conferences in December 2020 and January 2021. The Company will discuss its recent successful testing of DehydraTECHTM that showed improved delivery of two classes of drugs currently in use against HIV/AIDS with potential for use against SARS-CoV-2/COVID-19.

Event: Benzinga Global Small Cap Conference

Date: Tuesday December 8, 2020

Time: 3:45 PM ET

Registration: https://events.benzinga.com/registration-page...bQQAvD_BwE

Event: LD Micro Main Event

Date: Dec 15, 2020

Time: 11 AM ET

Registration: https://ve.mysequire.com/
Event: H.C. Wainwright BioConnect
Date: Jan 11-14, 2021

Registration: https://hcwevents.com/bioconnect/

Event: Virtual Biotech Showcase

Date: Jan 11-14, 2021

Registration: https://informaconnect.com/biotech-showcase/

Mr. Bunka will provide an overview on the Company's proprietary drug delivery technology, DehydraTECH™ as well as planned initiatives to enhance the Company's focus on solutions related to the regulated pharmaceutical and medical market segments in 2021. He will also discuss the Company's recent sale of its non-core assets in preparation for uplisting to a national securities exchange.

About Lexaria

Lexaria Bioscience Corp.'s (OTCQX:LXRP)(CSE:LXX) proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The Company's technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. DehydraTECH has repeatedly demonstrated since 2016 with cannabinoids and nicotine the ability to increase bio-absorption by up to 5-10x, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is planned to be further evaluated for orally administered bioactive molecules, including anti-virals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), and nicotine. Lexaria has licensed DehydraTECH to multiple companies including a world-leading tobacco producer for the development of smokeless, oral-based nicotine products and for use in industries that produce cannabinoid beverages, edibles, and oral products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 18 patents granted and approximately 60 patents pending worldwide. For more information, please visit www.lexariabioscience.com.


INVESTOR CONTACT:

ir@lexariabioscience.com

Phone: 866-221-3341


Read More: https://investorshangout.com/post/view?id=598...z6fwxXegKQ












Lexaria Bioscience Corp. (LXRPD) Stock Research Links

LXRPD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dynamic Automotive’s Car Show: Connecting Cars & Community

Updated Category News Views 2

Cars, Community, and Cause Today’s dialogue isn’t about upcoming IPOs or blue-chip stocks, it's about classic cars rolling into the spotlight for something bigger than horsepower or polish. On Sunday, September 27, from noon till three, Dynamic Automotive will host its 18th Annual Car Show in Urbana, Maryland. They’re not just showing off vintage steel; they’re...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 0

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
Potomac Edison Eyes Rate Hike for System Overhaul

Updated Category News Views 3

FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...

Continue Reading
Shenzhen Media Push: Shaping Asia-Pacific's Future

Updated Category News Views 0

A Metamorphosis in Shenzhen You ever hear about a place that rockets from obscurity to global significance in the blink of an eye? Well, Shenzhen, China is that place. Forty years ago, it was just a quaint fishing village. Fast forward a few decades, and you've got yourself an international powerhouse—a testament to China's rapid development strategy. Shenzhen is now...

Continue Reading
Court Enforces Design Rights: AEKE Blocked in Germany

Updated Category News Views 7

Court's Verdict: A Lesson in Design Protection Right out the gate, the Cologne Regional Court didn't pull any punches. Speediance got their 'Gym Monster' design yanked from under AEKE over in Germany. Legal swords were drawn after Speediance spotted AEKE's fitness gear looking a bit too familiar at the FIBO trade fair. Somebody should've told AEKE that a tapped shoulder...

Continue Reading
Dreame's High-Tech Kitchen Innovations Unveiled at IFA 2026

Updated Category News Views 0

The Gadgets Turning Heads at IFA 2026 Cooking's gone high-tech, and it's about time. At the IFA 2026 in Berlin, Dreame Technology rolled out some primo small kitchen appliances that might just leave the old-school gear collecting dust. We're talking slick machines across six major categories: air fryers, coffee gizmos, mixers, blenders, toasters, and treat makers. Forget...

Continue Reading
Parents Champion Meta's Online Safety Agreement

Updated Category News Views 5

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Continue Reading
Sotheby's to Auction Largest Flawless Paraiba Tourmalines

Updated Category News Views 2

Jaw-Dropping Gemstones Poised for Auction Glory The art of gemology isn't just about shiny rocks; it's a concoction of beauty, rarity, and, most importantly, value. And when the world's finest stones hit the auction block, it's akin to an epic performance in a long-awaited drama. On September 17, 2026, these precious Paraiba Tourmalines, fashioned by the adept hands of...

Continue Reading
Chris Auffenberg Buick: 1.9% APR Drives New Deals

Updated Category News Views 3

New Financing Options in Carbondale In a world where financing a car sometimes feels like predicting the weather—unreliable and erratic—Chris Auffenberg Buick is turning the tables down in Carbondale with a refreshing approach. They're trotting out a 1.9% APR financing option for those Buick lovers who qualify, all through GM Financial. It's the kind of deal that...

Continue Reading
storshangout.com/blog/news?page=2">More News Articles